Payoneer Global (NASDAQ:PAYO) versus Medical Cannabis Payment Solutions (OTCMKTS:REFG) Critical Comparison

Medical Cannabis Payment Solutions (OTCMKTS:REFG) and Payoneer Global (NASDAQ:PAYO) are both business services companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Valuation & Earnings

This table compares Medical Cannabis Payment Solutions and Payoneer Global”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medical Cannabis Payment Solutions	$140,000.00	N/A	-$30,000.00	N/A	N/A
Payoneer Global	$940.30 million	3.77	$93.33 million	$0.35	28.37

Payoneer Global has higher revenue and earnings than Medical Cannabis Payment Solutions.

Insider & Institutional Ownership

82.2% of Payoneer Global shares are owned by institutional investors. 5.6% of Payoneer Global shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Medical Cannabis Payment Solutions and Payoneer Global’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medical Cannabis Payment Solutions	N/A	N/A	N/A
Payoneer Global	13.82%	17.78%	1.73%

Volatility & Risk

Medical Cannabis Payment Solutions has a beta of -0.13, indicating that its share price is 113% less volatile than the S&P 500. Comparatively, Payoneer Global has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Medical Cannabis Payment Solutions and Payoneer Global, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medical Cannabis Payment Solutions	0	0	0	0	0.00
Payoneer Global	0	1	5	1	3.00

Payoneer Global has a consensus target price of $11.36, indicating a potential upside of 14.37%. Given Payoneer Global’s stronger consensus rating and higher possible upside, analysts plainly believe Payoneer Global is more favorable than Medical Cannabis Payment Solutions.

Summary

Payoneer Global beats Medical Cannabis Payment Solutions on 12 of the 12 factors compared between the two stocks.

About Medical Cannabis Payment Solutions

Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming. On August 12, 2024, Medical Cannabis Payment Solutions, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.

About Payoneer Global

Payoneer Global Inc. operates as a financial technology company. It operates a payment infrastructure platform that provides customers with a one-stop, global, multi-currency account to serve their accounts receivable and accounts payable needs. The company delivers a suite of services that includes cross-border payments, physical and virtual MasterCard cards, working capital, risk management, and other services. It also offers various payment options with minimal integration required, full back-office functions, and customer support offered. The company's platform delivers bank-grade security, stability, and redundancy. It serves customers, such as small and medium-sized businesses in approximately 190 countries and territories worldwide. Payoneer Global Inc. was founded in 2005 and is headquartered in New York, New York.